Science Corp, a brain-computer interface company, raises $400 million in a Series D funding round that values it at $3.5 billion, according to multiple outlets. The company says the investment is intended to help bring its medical devices to market and scale its work described as vision-restoring or anti-blindness.
Outlets also describe the round’s participants. SiliconANGLE and The Next Web both say the funding is led by Khosla Ventures and include the Ackman Oxman Institute, Tenet Healthcare, and Y Combinator among the backers named in Science’s blog post. TechCrunch reports the same core figures and frames the announcement around the company’s post-funding valuation. The Next Web adds attribution to a person familiar with the deal for the valuation figure.